Olanzapine Long-Acting Injection: A Review of its Use in the Treatment of Schizophrenia

ISSN： 0012-6667

Source： Drugs, Vol.70, Iss.17, 2010-12, pp. : 2289-2313

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Acting Risperidone: A Review of Its Use in Schizophrenia

By Tracy Swainston Harrison Goa K.L.

CNS Drugs, Vol. 18, Iss. 2, 2004-01 ,pp. : 113-132

Adis International

Access to resources Recommend Favorite

Risperidone Long-Acting Injection in the Treatment of First Episode Schizophrenia

By Rocca P. Sandei L. M. Bava I. Frieri T.

Current Psychopharmacology, Vol. 2, Iss. 1, 2013-02 ,pp. : 29-36

Bentham Science Publishers

Access to resources Recommend Favorite

Risperidone Long-Acting Injection in the Treatment of First Episode Schizophrenia

Current Psychopharmacology, Vol. 2, Iss. 1, 2013-02 ,pp. : 29-36

Bentham Science Publishers

Access to resources Recommend Favorite

Octreotide Long-Acting Release (LAR): A Review of its Use in the Management of Acromegaly

By Yang Lily P.H. Keating Gillian M.

Drugs, Vol. 70, Iss. 13, 2010-09 ,pp. : 1745-1769

Adis International

Access to resources Recommend Favorite

Octreotide Long-Acting Release (LAR): A Review of its Use in the Management of Acromegaly

By McKeage K. Cheer S. Wagstaff A.J.

Drugs, Vol. 63, Iss. 22, 2003-01 ,pp. : 2473-2499

Adis International

Access to resources Recommend Favorite